| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Sophia Randolph last filed a Form 4 in August 2024, as Chief Medical Officer at ALXO. From March 2021 to August 2024, the filings on record show 0 open-market purchases and 15 sales. Sophia Randolph's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Sophia Randolph's trades have earned a strong insider score of 88/100 across 15 rated trades. Over a 12-month horizon, 93.3% of those trades were profitable, with an average 12-month return of +70.7%.
At the last filing, the largest reported position was 325,711 shares of ALXO. The ALXO filings lean toward selling, a net 96,968 shares.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $54.90 | $405,527.15 | -4.1% | +11.8% | -81.5% | |
| Jun 10, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $60.88 | $449,696.81 | -4.0% | +21.1% | -88.9% | |
| May 10, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $61.97 | $457,771.58 | -3.8% | +5.8% | -84.1% | |
| Apr 12, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $59.43 | $438,977.74 | -3.7% | -5.5% | -70.3% | |
| Mar 10, 2021 | ALXO Alx Oncology Holdings Inc | Chief Medical Officer | Sell | 7,387 | $74.34 | $549,173.18 | -3.5% | -20.7% | -74.9% |